Limitando o acesso a terapias não aprovadas: Uma prática paternalista?

Martin Šolc

doi:10.18593/ejjl.23247

Autores

Martin Šolc

DOI:

https://doi.org/10.18593/ejjl.23247

Palavras-chave:

Legislação sanitária, Terapias não aprovadas, Terapias com células-tronco, Paternalismo médico, República Tcheca

Resumo

O objetivo deste artigo é responder sobre se são permitidas as limitações do acesso a terapias não aprovadas fora dos ensaios clínicos, à luz do paradigma moderno dos cuidados de saúde, que se baseia na autonomia de vontade dos pacientes. O debate do texto se concentra nas terapias que consistem no fornecimento de medicamentos não registrados. A lei é muitas vezes restritiva ao permitir que os pacientes recebam terapias experimentais, mesmo que concedam consentimento totalmente informado. A lei tcheca e um recente caso tcheco de terapia com células-tronco não aprovada fornecem uma base para a análise do problema com conclusões universalmente aplicáveis. Argumentamos que a regulamentação do acesso a terapias não aprovadas atende a um importante interesse público da proteção da confiança pública no sistema de saúde e, portanto, é justificada. A lei deve permitir apenas o acesso a terapias experimentais com justificativas científicas suficientes. Sob certas condições, os pacientes podem cobrir os custos da terapia.

Downloads

Não há dados estatísticos.

Referências

Amyotrophic Lateral Sclerosis (ALS) Fact Sheet. (2019). National Institute of Neurological Disorders and Stroke. Retrieved from https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet

Beauchamp, T. L., & Childress, J. F. (2013). Principles of Biomedical Ethics. (7th ed.). New York: Oxford University Press.

Caplan, A. (2016). Medical Ethicist Arthur Caplan Explains Why He Opposes “Right-to-Try” Laws. Cancer Network, 30(1). Retrieved from https://www.cancernetwork.com/oncology-journal/medical-ethicist-arthur-caplan-explains-why-he-opposes-right-try-laws

Cook, N., Hansen, A. R., Siu, L. L., & Abdul Razak, A. R. (2015). Early phase clinical trials to identify optimal dosing and safety. Molecular Oncology, 9(5), 97-1007.

Dostál, O. (2014). Poslední naděje za 150 000 korun. [The Last Hope for 150 000 CZK.] Medical Tribune. Retrieved from http://www.tribune.cz/clanek/33793-posledni-nadeje-za-korun

Durisotto v. Italy, application No. 62804/13 European Court of Human Rights (the decision of 6 May 2014).

Europe’s 10 Largest Acute Care Hospitals Have Sizeable Clinical Pathology Laboratories. (2010, April 23). Dark Daily. Retrieved from https://www.darkdaily.com/europes-10-largest-acute-care-hospitals-have-sizeable-clinical-pathology-laboratories-423

Harmon, K. (2012, January 7). How Has Stephen Hawking Lived Past 70 with ALS? Scientific American. Retrieved from https://www.scientificamerican.com/article/stephen-hawking-als/

Harvey, R. A., Clark, M. A., Finkel, R., Rey, J. A., & Whalen, K. (2012). Lippincott’s Illustrated Reviews: Pharmacology. (5th ed.). Baltimore, Philadelphia: Lippincott Williams & Wilkins, Wolters Kluwer.

Hlavatý, T. (2016). Základy klinického výskumu. [The Basics of Clinical Research.]. Bratislava, Praha: Grada Publishing..

ICD-11 Diagnosis of Factitious Disorder Imposed on Self. (2019). Retrieved from https://icd.who.int/dev11/f/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f790764418

Kuře, J. (2009). Human Embryonic Stem Cell Research in Central and Eastern Europe: A Comparative Analysis of Regulatory and Policy Approaches. In A. Plomer, & P. Torremans, Embryonic Stem Cell Patents: European Law and Ethics. Oxford: Oxford University Press.

Maron, D. F. (2016, June 30). Unproved Stem Cell Clinics Proliferate in the U.S. Scientific American. Retrieved from https://www.scientificamerican.com/article/unproved-stem-cell-clinics-proliferate-in-the-u-s/

Munzarová, M. (2005). Lékařský výzkum a etika. [Medical Research and Ethics]. Praha: Grada Publishing.

Obchod s nadějí. [The Business with Hope.]. (2015, November 9). Česká televize. [The Czech Television]. Retrieved from https://www.ceskatelevize.cz/ivysilani/1142743803-reporteri-ct/215452801240037/obsah/434334-obchod-s-nadeji

Obchod s nadějí II. [The Business with Hope II.]. (2016, May 30). Česká televize. [The Czech Television]. Retrieved from https://www.ceskatelevize.cz/porady/1142743803-reporteri-ct/216452801240020/video/475045

Pegg, S. (2019, February 12). Body modification – when consent is not a defence. The Conversation. Retrieved from https://theconversation.com/body-modification-when-consent-is-not-a-defence-87816

Phases of clinical trials. (2019). National Comprehensive Cancer Network. Retrieved from https://www.nccn.org/patients/resources/clinical_trials/phases.aspx

Resnik, D. B. (2018). The Ethics of Research with Human Subjects. Cham, Switzerland: Springer International Publishing AG.

Rychlík, M. (2016, June 1). Pád profesorky Evy Sykové. [The Fall of Professor Eva Syková.] Lidové noviny. Retrieved from https://www.pressreader.com/czech-republic/lidove-noviny/20160601/281573764949024

Salač, J. (2019). Informovaný souhlas jako nástroj vyrovnání informačního deficitu ve vztahu lékař-pacient. [Informed Consent as an Instrument of Equalizing the Information Asymmetry in the Physician-Patient Relationship]. Paneurópske právnické listy, 2(1). Retrieved from http://www.paneuropskepravnickelisty.sk/index.php/salac-j/

Šolc, M. (2018). Právo, etika a kmenové buňky. [Law, Ethics and Stem Cells.]. Praha: Wolters Kluwer.

Šustek, P. (2016a). Klinický výzkum. [Clinical Research.] In P. Šustek, & T. Holčapek, Zdravotnické právo. [Health Law]. Praha: Wolters Kluwer.

Šustek, P. (2016b). Medicínský výzkum. [Medical Research.]. In P. Šustek, & T. Holčapek, Zdravotnické právo. [Health Law]. Praha: Wolters Kluwer.

Šustek, P. (2016c). Náležitý odborný postup (lex artis). Obecně. [Appropriate professional procedure (lex artis). In P. Šustek, & T. Holčapek, Zdravotnické právo. [Health Law]. Praha: Wolters Kluwer.

Šustek, P., & Šolc, M. (2018). Selling and Owning Human Body Parts in the Light of Human Rights: the Ideal and the Current Practice in the Czech Republic. In P. Šturma, V. A. Mozetic, Business and Human Rights. Waldkirchen: rw&w Science & New Media Passau-Berlin-Prague.

Šustek, P. (2018). Two Decades of the Convention on Biomedicine: Has It Been Any Good? In P, Šturma, Czech Yearbook of Public & Private International Law. Česká ročenka mezinárodního práva veřejného a soukromého. Praha: Česká společnost pro mezinárodní právo, 2018. Retrieved from https://rozkotova.cld.bz/CYIL-vol-9-2018/276

Teixeira Zorzanelli, R., Speroni, A. V., Menezes, R. A., & Leibing, A. (2017, January/March). Pesquisa com células-tronco no Brasil: a produção de um novo campo científico. [Stem cell research in Brazil: the production of a new field of science.] História, Ciências, Saúde – Manguinhos, 24(1), 129-144.

The Czech Republic Act No. 40 Coll., Criminal Code (2009).

The Czech Republic Act No. 48 Coll., on Public Health Insurance (1997).

The Czech Republic Act No. 268 Coll., on Medical Devices (2014).

The Czech Republic Act No. 372 Coll., on Health Services (2011a).

The Czech Republic Act No. 373 Coll., on Specific Health Services (2011b).

The Czech Republic Act No 378 Coll., on Pharmaceuticals (2007).

Wiffen, P., Mitchell, M., Snelling, M., & Stoner, N. (2012). Oxford Handbook of Clinical Pharmacy. (2nd ed.). Oxford: Oxford University Press.

Žebříčku nejcitovanějších českých vědců vládnou chemici. [The List of the Most Cited Czech Scientists is Ruled by the Chemists.]. (2018, May 7). Česká pozice. Retrieved from http://ceskapozice.lidovky.cz/zebricku-nejcitovanejsich-ceskych-vedcu-vladnou-chemici-pel-/tema.aspx?c=A180504_110119_pozice-tema_houd